Concussion Clinical Trials 2023

Concussion Clinical Trials 2023

Concussion research studies recruiting patients in 2023 need your help. Receive premium care & cutting edge treatments by enrolling in concussion clinical trials today.

Concussion Clinical Trials

Here are the 6 most popular medical studies for concussion

Popular filter options for concussion trials

Post-Concussion Syndrome Clinical Trials

View 37 Post-Concussion Syndrome medical studies.

PCS Clinical Trials

View 26 PCS medical studies.

Calgary, Alberta

Hormone Therapy

Melatonin for Concussion

Recruiting0 awardsPhase 2 & 3
Calgary, Alberta

PURPOSE: The long-term goal of this line of research is to develop rational, biologically based evidence for the treatment of post-concussion syndrome (PCS) in children. The objective of this application is to examine the effect of melatonin on the symptoms of PCS and its neurobiology using integrated neurodiagnostic techniques in children. OVERVIEW: PCS is a constellation of clinical symptoms including physical (i.e. headaches), cognitive (i.e. memory), and behavioral disturbances. PCS is associated with significant morbidity in the child and his/her family), and yet there are no evidence-based medical treatments available. This suggests an urgent need to develop novel treatment options to improve outcomes for children suffering from PCS. Melatonin has several relevant mechanisms of action, and neuroprotective effects. Recent research suggests that the explanations for persistent PCS symptoms may be due to alterations in neurotransmissions and neuronal circuitry, particularly involving the dorsolateral prefrontal cortex (DLPFC). Investigators have two specific aims: To determine if treatment with melatonin improves PCS in children following mild traumatic brain injury. Hypothesis: treatment of mTBI children with PCS with 3mg or 10mg of oral melatonin for 28 days will result in a decrease in PCS symptoms as compared with placebo. Effects will be dose-dependent and may be independent of sleep effects. Methods: A randomized double blind, placebo controlled trial (RCT); Outcome measure is a PCS symptom questionnaire. A subsequent RCT will then be performed using the optimal melatonin dose at a second centre. To understand the neurophysiological mechanisms of paediatric PCS and assess any resultant effects of treatment with melatonin. Methods: A case-controlled study within the RCT, using functional MRI and Transcranial Magnetic Stimulation to investigate the neurophysiological properties of paediatric mTBI before and after treatment; Treatment groups from the RCT will be compared with two control groups: i) normal controls and ii) asymptomatic mTBI children. SIGNIFICANCE: This study has the potential to 1) provide a safe and effective treatment for PCS and 2) will provide valuable information about the neurophysiological properties of the brain associated with PCS following mTBI in children and how these change with symptom resolution.

Concussion Clinical Trials With No Placebo

View 98 concussion medical studies that do not have a placebo group.

View More Concussion Trials

See another 73 medical studies focused on concussion.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to concussion

What are the top hospitals conducting concussion research?

When it comes to advancing our understanding of concussions, several top hospitals across the United States are leading the way. In Pittsburgh, Pennsylvania, the University of Pittsburgh is at the forefront with three active concussion trials and a total of four trials conducted thus far. Since recording their first concussion trial in 2017, this hospital has been dedicated to investigating ways to improve diagnosis and treatment for this common brain injury. In Hines, Illinois, Edward Hines Jr. VA Hospital is also contributing significantly with three ongoing concussion trials and a history of four previous studies since their inaugural trial in 2019.

Meanwhile, Mayo Clinic in Rochester, Minnesota is making strides as well with its current involvement in three active concussion trials and two completed studies overall since initiating research efforts on this condition in 2019. On the West Coast at Naval Medical Center San Diego in California, researchers have been diligently working on concussions since their first recorded trial back in 2013. With two active clinical trials and a total of four conducted experiments in their arsenal, they continue to make valuable contributions towards improving patient outcomes.

Further expanding our knowledge on concussions is taking place at Milwaukee's Medical College of Wisconsin where researchers are actively engaged with two ongoing clinical trials while building upon four prior investigations dating back to 2015.

Across these esteemed institutions scattered throughout the country- from Pittsburgh to Hines; Rochester to San Diego; Milwaukee- medical professionals are focused on identifying better methods for diagnosing and treating concussions effectively.With every study they undertake or complete,it brings us closer towards enhancing care provision for those affected by these head injuries that can potentially impact lives both inside military services & civilian community.This collective effort demonstrates commitment towards improving quality-of-life post-concussion not only among service members but also athletes,falls victims,and anyone who may have experienced such incidents

Which are the best cities for concussion clinical trials?

When it comes to concussion clinical trials, several cities are at the forefront of research and development. Vancouver, British Columbia leads with 14 active trials exploring treatments like Cognitive Behavioural Therapy (CBT), Guideline implementation tools, and Graded Exposure Therapy. Calgary, Alberta follows closely behind with 10 ongoing studies focused on interventions such as rTMS, Symptom-specific Headache Treatment, and Melatonin 10mg. Toronto, Ontario also contributes significantly with 6 active trials investigating approaches like Graded Exposure Therapy and Newly designed computer monitors. Additionally, Seattle in Washington state and Pittsburgh in Pennsylvania each have 5 active trials examining various treatment options for concussions. These cities provide valuable opportunities for individuals affected by concussions to participate in groundbreaking clinical research aimed at improving outcomes and enhancing care strategies.

Which are the top treatments for concussion being explored in clinical trials?

Clinical trials are currently exploring several promising treatments for concussions. Among these, HS-1000 recording is leading the way with two active trials and a total of two concussion trials since its debut in 2015. Another noteworthy contender is tdcs in Youth with mild traumatic brain injury, which has embarked on one active trial and stands as the sole concussion trial listed thus far since its introduction in 2023. These innovative treatments offer hope for improved management and recovery from concussions, paving the way towards better outcomes for individuals affected by this condition.

What are the most recent clinical trials for concussion?

Exciting progress is being made in the field of concussion research, with recent clinical trials exploring novel approaches to treatment. One such trial focuses on active iTBS, a non-invasive brain stimulation technique that shows potential for aiding concussion recovery. Another study investigates active left frontal HD-tdcs, which targets specific areas of the brain to mitigate symptoms associated with concussions. Additionally, high-dose exercise has emerged as a promising intervention for individuals recovering from concussions. These advancements provide hope for improving outcomes and quality of life for those affected by this common injury.

What concussion clinical trials were recently completed?

Recent advancements in concussion research have seen the completion of several noteworthy clinical trials. In October 2020, a trial led by Michael Rippee, MD, investigated the potential benefits of Ghrelin (OXE-103) for individuals with concussions. Another significant study conducted by The University of Texas Health Science Center at San Antonio concluded in February 2019 and examined the use of Quetiapine Fumarate as a potential treatment for concussions. These completed trials represent important contributions to our understanding and management of this complex neurological condition.